Hemostats & Tissue Sealants

Hemostats & Tissue Sealants Market by Product Type (Hemostats, Tissue sealants), Application (Burn & Trauma Cases, Cardiovascular, General Surgeries), End User - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the hemostats & tissue sealants market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[194 Pages Report] The Hemostats & Tissue Sealants Market size was estimated at USD 10.50 billion in 2023 and expected to reach USD 11.78 billion in 2024, at a CAGR 12.33% to reach USD 23.72 billion by 2030.

Hemostats & Tissue Sealants Market
To learn more about this report, request a free PDF copy

Hemostats & tissue sealants are used in several surgical disciplines to stop bleeding mechanically or by augmenting the coagulation cascade. Tissue sealants are products that bind to and close cuts in tissue. The increasing aging population, the rising prevalence of chronic conditions and diseases, and the need for timely surgeries are expected to drive the market's growth. Several government initiatives to focus on wound closure management and easy availability of hemostats & tissue sealants are the market growth factors. However, the higher cost of surgical procedures, the rising prices of surgical products and treatments, and strict regulations regarding the utilization of hemostats & tissue sealants hamper the market growth. Technological advancement in hemostats & tissue sealants products and increasing use of biopolymer-based hemostats are expected to create a significant market opportunity in the forecasted period.

Hemostats & Tissue Sealants Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Regional Insights

The Americas has a significant presence in the hemostats & tissue sealants market owing to the growing prevalence of cardiovascular diseases, diabetes, and cancer and increasing health expenditure within the region. According to the National Health Expenditure Accounts, U.S. healthcare spending increased by 2.7% in 2021, reaching USD 4.3 trillion or USD 12,914 per person to address rising healthcare issues. The launch of advanced and innovative products, the rising number of surgeries, and the increasing demand for more effective and quicker healing post-surgery are enhancing the demand for hemostats & tissue sealants in the European region. The proliferating approvals and clearance of hemostats & tissue sealants have expanded the availability of new products in Europe. The hemostats & tissue sealants market is growing in Asia-Pacific due to increased medical tourism and surgical procedures volume.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemostats & Tissue Sealants Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemostats & Tissue Sealants Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Olympus Launches EndoClot Hemostatic Agents and Submucosal Injection Agent in European Markets

    Olympus, a global leader in medical innovation, has recently launched two advanced medical tools in European markets that are set to revolutionize hemostats and tissue sealants. The first tool, EndoClot, is a hemostatic agent designed to quickly stop bleeding in various medical procedures, reducing the need for surgical intervention and enhancing patient care. The second tool, Submucosal Injection Agent, is a highly innovative tissue sealant used in endoscopic procedures to support the prevention of further bleeding and enable effective wound healing. Olympus has consistently shown a commitment to driving innovation in the medical industry, and these products are a testament to their dedication to advancing patient care. [Published On: 2023-04-20]

  • Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations

    Corza Medical has signed a definitive agreement to acquire Takeda's Tachosil manufacturing operations. Tachosil is a surgical patch used for hemostasis and tissue sealing. The acquisition is expected to strengthen Corza's position as a leading player in the market for hemostats and tissue sealants. The companies have not disclosed the financial terms of the deal. The acquisition aligns with Corza's mission of developing innovative medical solutions to improve patient outcomes. With the addition of Tachosil, Corza will be able to enhance its existing portfolio and offer healthcare providers with more options for managing surgical bleeding and tissue closure during surgical procedures. [Published On: 2023-04-06]

  • Advamedica Inc Announces FDA Clearance for Ax-Surgi Surgical Hemostat

    Advamedica recently announced the exciting news of FDA clearance for their innovative Hemostat & Tissue Sealant products. This is a game-changing development, as the new products offer exceptional hemostatic and sealant capabilities, while also being safe and easy to use. With this clearance, Advamedica can now bring their products to market and provide healthcare professionals with the tools they need to improve patient outcomes. The company has worked tirelessly to develop these products, and their hard work has paid off with FDA recognition of their safety and effectiveness. As a leader in hemostats and tissue sealants, Advamedica is poised to make a significant impact in the medical field and provide a solution to a critical medical need. [Published On: 2023-03-21]

Key Company Profiles

The report delves into recent significant developments in the Hemostats & Tissue Sealants Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advanced Medical Solutions Group PLC, Aegis Lifesciences Private Limited., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cardinal Health, Inc., CooperSurgical, Inc., CryoLife, Inc., CSL Behring, CuraMedical B.V., Grifols, S.A., Hemostasis, LLC, Hologic, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., KAKEN PHARMACEUTICAL CO., LTD., KATSAN Katgüt Sanayi ve Tic. A.Ş., Medline Industries, LP., Medtronic PLC, Olympus Corporation, Owens & Minor, Pfizer, Inc., Smith & Nephew PLC, Stryker Corporation, Teleflex Incorporated, Terumo Corporation, Thermo Fisher Scientific Inc., Vivostat A/S, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Hemostats & Tissue Sealants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product Type
    • Hemostats
      • Active Hemostats
      • Flowable Hemostats
      • Mechanical Hemostats
    • Tissue sealants
      • Fibrin Sealants
      • Synthetic Sealants
  • Application
    • Burn & Trauma Cases
    • Cardiovascular
    • General Surgeries
    • Neurological
    • Orthopedic
    • Reconstructive Surgeries
    • Urological
  • End User
    • Ambulatory Surgical Centers
    • Hospitals
    • Specialty Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Hemostats & Tissue Sealants Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemostats & Tissue Sealants Market?
  3. What are the technology trends and regulatory frameworks in the Hemostats & Tissue Sealants Market?
  4. What is the market share of the leading vendors in the Hemostats & Tissue Sealants Market?
  5. Which modes and strategic moves are suitable for entering the Hemostats & Tissue Sealants Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Hemostats & Tissue Sealants Market, by Product Type
  7. Hemostats & Tissue Sealants Market, by Application
  8. Hemostats & Tissue Sealants Market, by End User
  9. Americas Hemostats & Tissue Sealants Market
  10. Asia-Pacific Hemostats & Tissue Sealants Market
  11. Europe, Middle East & Africa Hemostats & Tissue Sealants Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 470]
  16. List of Companies Mentioned [Total: 30]
How Trusted Online Medical Device Channels are Revolutionizing the Availability of Hemostats and Tissue Sealants
June 26, 2023
How Trusted Online Medical Device Channels are Revolutionizing the Availability of Hemostats and Tissue Sealants
Hemostats and tissue sealants are indispensable tools in the world of surgery. They play a crucial role in controlling bleeding, promoting wound healing, and mitigating the risk of surgical complications. However, the availability of these essential medical devices can be a challenge, especially for smaller healthcare providers with limited budgets and resources. Fortunately, trusted online medical device channels are revolutionizing the way in which healthcare providers access and purchase hemostats and tissue sealants. This blog post explores how these channels are making a real difference in the industry.

Increased Accessibility:

One of the most significant benefits of using trusted online medical device channels is increased accessibility. Thanks to the internet, healthcare providers can now browse an extensive range of hemostats and tissue sealants from multiple manufacturers and suppliers. They can compare prices, read product reviews, and place orders from the comfort of their office or clinic. This convenience not only saves time and effort but also expands their options, making it easier to find the most suitable products for their patients and their budget.

Competitive Pricing:

Another advantage of using online channels is competitive pricing. Online retailers often offer reduced prices than brick-and-mortar stores, as they have less overhead costs and can pass on these savings in terms of offers and discounts to their customers. Additionally, online channels may offer bulk discounts, loyalty rewards, and seasonal promotions that further reduce the cost of hemostats and tissue sealants. This means that healthcare providers can access high-quality products at affordable prices without compromising on patient care.

Trusted Quality:

One of the concerns healthcare providers have with purchasing hemostats and tissue sealants online is quality assurance. However, trusted online medical device channels carefully curate their product offerings and adhere to strict quality control standards. They partner with reputable manufacturers and suppliers who are experienced in producing safe, reliable, and effective medical devices. In addition, they often provide product certifications, product literature, and technical support to ensure that healthcare providers can make informed decisions and use these devices with confidence.

Efficient Delivery:

Finally, online channels offer efficient delivery options that can meet the needs of busy healthcare providers. Providers can choose from multiple shipping methods, such as standard shipping, expedited shipping, or even same-day delivery. This means that healthcare providers can quickly obtain these vital medical devices when they need them the most, without worrying about stock shortages or long delivery times. Combined with the other benefits of online channels, efficient delivery options make it easier and more cost-effective for healthcare providers to manage their hemostats and tissue sealant inventory.

Trusted online medical device channels are changing the way in which healthcare providers access and purchase hemostats and tissue sealants. They offer increased accessibility, competitive pricing, trusted quality, and efficient delivery options that can benefit healthcare providers of all sizes and specializations. As online channels continue to grow and evolve, the future of hemostats and tissue sealants is brighter than ever before. By embracing these channels, healthcare providers can achieve better patient outcomes and improve the overall quality of care.

Frequently Asked Questions
  1. How big is the Hemostats & Tissue Sealants Market?
    Ans. The Global Hemostats & Tissue Sealants Market size was estimated at USD 10.50 billion in 2023 and expected to reach USD 11.78 billion in 2024.
  2. What is the Hemostats & Tissue Sealants Market growth?
    Ans. The Global Hemostats & Tissue Sealants Market to grow USD 23.72 billion by 2030, at a CAGR of 12.33%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.